Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not di...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Main Authors: Constantinescu, Catalin, Pasca, Sergiu, Tat, Tiberiu, Teodorescu, Patric, Vlad, Catalin, Iluta, Sabina, Dima, Delia, Tomescu, Dana, Scarlatescu, Ecaterina, Tanase, Alina, Sigurjonsson, Olafur Eysteinn, Colita, Anca, Einsele, Hermann, Tomuleasa, Ciprian
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2020
Assuntos:
Hypothesis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264828/
https://ncbi.nlm.nih.gov/pubmed/32474415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000742
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares